Molecular-chemical basis of emotional states and reinforcement

Uspekhi Fiziologicheskikh Nauk

Volumn 37, Issue 1, 2006, Pages 78-83

  Bazyan, A S ^a   Grigoryan, G A ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

Behaviour; Conditioned reflex; Consolidation; Dopamine; Emotion; Ionotropic receptors; Memory; Mesolimbic system; Methabotropic receptors; Motivation; Neural networks; Neuro modulator; Neuron; Reinforcement; Serotonin

Indexed keywords

CONDITIONED REFLEX; DOPAMINE; IONOTROPIC RECEPTORS; MESOLIMBIC SYSTEM; METHABOTROPIC RECEPTORS; NEURO-MODULATORS; SEROTONIN;

AMINES; CONSOLIDATION; MOTIVATION; NEURAL NETWORKS; NEUROLOGY; REINFORCEMENT;

BRAIN;

ANIMAL; BEHAVIOR; BRAIN; BRAIN LEVEL; CONDITIONED REFLEX; EMOTION; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; BEHAVIOR; BRAIN; BRAIN CHEMISTRY; CONDITIONING, CLASSICAL; EMOTIONS; HUMANS;

EID: 33645061296     PISSN: 03011798     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (149)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Russian source
10. Russian source
11. Russian source
12. Russian source
13. Russian source
14. Russian source
15. Russian source
16. Russian source
17. Russian source
18. Russian source
19. Russian source
20. Russian source
21. Russian source
22. Russian source
23. Russian source
24. Russian source
25. Russian source
26. Russian source
27. Russian source
28. Russian source
29. Russian source
30. Russian source
31. Russian source
32. Acquas A., Di Chiara G. Depression of mesolimbic dopamine transmission and ensitization to morphine during opiate abstinence // J. Neurochem. 1992. V. 58. No 5. P. 1620-1625.
33. 1 receptor stimulation // Eur. J. Pharmacol. 1992. V. 216. No 2. P. 157-166.
34. Balster L.R., Johanson C.E., Harris R.T., Schuster C.R. Phencyclidine self-administration in the rhesus monkey // Pharmacol. Biochem. Behav. 1973. V. 1. P. 167-172.
35. Balster L.R., Willets J. Phencyclidine: a drug of abuse and a tool for neuroscience research // Pharmacological Aspects of Drug Dependence: Toward and Integrated Neurobehavioral Approach. Handbook of Experimental Pharmacology / Eds Schuster C.R., Gust S.W., Kuhar M.J. Berlin: Springer-Verlag, 1995. V. 118-162.
36. Bassarco V., Di Chiara G. Modulation of feeding-in-duced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state. // Eur. J. Neurosci. 1999. V. 11. No. 12. P. 4389-4397.
37. Bazyan A.S. Principles of functioning and physiological role of autoadrenoreceptors of mammalian nervous system // Biogenic Amines. 1992. V. 9. No 3. P. 225-250.
38. Bazyan A.S., Gelsova V.M., Orlova N.V. Haloperidol catalepsy consolidation in the rat as a model of neuromodulatory intecration // Neuroscience. 2000. V. 99. No 2. P. 279-288.
39. Bazyan A.S., Zhulin V.V., Karpova M.N. et al. Longterm reduction of benzodiazepine receptor density in the rat cerebellum by acute seizures and kindling and its recovery six months later by a pentylenetetrazole challenge // Brain Res. 2001a. V. 888. No 2. P. 212-220.
40. Bazyan A.S., Getsova V.M., Orlova N.V. Pharmacological reminder of emotional state the retrieval of traces from amnestic memory // Neurosci. Behav. Physiol. 2001b. V. 31. No 5. P. 509-515.
41. Becker J.B., Rudick C.N., Jenkins W.J. The role of dopamine in the nucleus accumbens and striatum during sexual behavior in the female rat // J. Neurosci. 2001. V. 21. No 9. P. 3236-3241.
42. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? // Brain Res. Rev. 1998. V. 28. No 3. P. 309-369.
43. Bindra D. A motivational view of learning, performance and behavior modification // Psychol. Rev. 1974. V. 81. P. 199-213.
44. Bitran D., Shiekh M., McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors // J. Neuroendocrinol. 1995. V. 7. No 3. P. 171-177.
45. Blackburn J.R., Phillips A.G., Jakubovic A., Fibiger H.C. Dopamine and preparatory behavior: II. A neurochemical analysis. // Behav. Neurosci. 1989. V. 103. No 1. P. 15-23.
46. Blum K., Braverman E.R., Holder J.M. et al. Reward deficiency syndrom: a biogenetic model for the diagnosis and treatment of impulsive, addictive and compulsive behaviours // J. Psychoactive Drugs. 2000. V. 32. P. 1-112.
47. Bobula B., Tokarski K., Hess G. Repeated imipramine administration enhances the effects of NMDA receptor ligands on synchronous activity in rat frontal cortex in vitro // Pol. J. Pharmacol. 2001. V. 53. No 6. P. 635-639.
48. Brot M.D., Akwa Y., Purdy R.H. et al. The anxiolyticlike effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. // Eur. J. Pharmacol. 1997. V. 325. No 1. P. 1-7.
49. Brunner H.G., Nelen M., Drakefield X.O. et al. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A // Science. 1993. V. 262. P. 578-580.
50. Bunin M.A., Wightman R.M. Paracrine neurotransmission in the CNS: involvement of 5-HT // Trend. Neurosci. 1999. V. 22. No 9. P. 377-382.
51. Caine S.B., Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat // J. Pharmacol. Exp. Ther. 1994. V. 270. No 1. P. 209-218.
52. 2 receptor antauonists // J. Neurosci. 2002. V. 22. No 7. P. 2977-2988.
53. Cases O., Self I., Grimsby J., Gaspar P. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA // Science. 1995. V. 268. P. 1763-1766.
54. Chardenot P., Roubert C., Galiegue S. et al. Expression profile and up-regulation of PRAX-1 mRNA by antide-pressant treatment in the rat brain // Mol. Pharmacol. 2002. V. 62. No 6. P. 1314-1320.
55. Coulter D.A. Epilepsy-associated plasticity in gamma-aminobutyric acid receptor expression, function, and inhibitory synaptic properties // Int. Rev. Neurobiol. 2001. V. 45. P. 237-252.
56. Dackis CA., Gold M.S. New concepts in cocaine addiction: the dopamine depletion hypothesis // Neurosci. Biobehav. Rev. 1985. V. 9. P. 469-467.
57. D'Aquila P.S., Peana A.T., Panin F. et al. Reversal of antidepressant-induced dopaminergic behavioural supersensitivity after long-term chronic imipramine withdrawal // Eur. J. Pharmacol. 2003. V. 458. No 1-2. P. 129-134.
58. Datla K.P., Ahier R.G., Young A.M. et al. Conditioned appetitive stimulus increases extracellular dopamine in the nucleus accumbens of the rat. // Eur J Neurosci. 2002. V. 16. No 10. P. 1987-1993.
59. Dekeyne A., Gobert A., Auclair A. et al. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors // Psychopharmacology. (Berl.) 2002. V. 162. No 2. P. 156-167.
60. De La Garza R., Jentsch J.D., Verrico C.D., Roth R.H. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine // Brain Res. 2002. V. 958. No 1. P. 20-27.
61. De Maeycr E., Self I., Cases O., Caspar P. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking monoamine oxidase A // Violence: From Biology to Sosiety / Ed. Grisolla J.S. Berlin: Elsevier Science. 1997. P. 71-78.
62. De Mantis M.G., Gambarana C., Meloni D. Alpha-methyl-para-tyrosine antagonizes the effect of chronic imipramine on learned helplessness in rats // Eur. J. Pharmacol. 1993. V. 249. No 2. P. 179-183.
63. Diana M., Melis M., Muntoni A.L., Gessa G.L. Mesolimbic dopaminergic decline after cannabinoid withdrawal // Proc. Nat. Acad. Sci. USA. 1998. V. 95. No 17. P. 10269-10273.
64. Di Chiara G. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. // Behav. Brain Res. 2002. V. 137. No 1-2. P. 75-114.
65. Di Chiara G., Tanda G., Bassareo V. et al. Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine // Ann. N.Y. Acad. Sci. 1999. V. 877. P. 461-485.
66. Evenden J.L. The pharmacology of impulsive behaviour in rats II: the effects of amphetamine, haloperidol, imipramine, chlordiazepoxide and other drugs on fixed consecutive number schedules (FCN 8 and FCN 32) // Psychopharmacology. (Berl.) 1998. V. 138. No 3-4. P. 283-294.
67. Evenden J.L. The pharmacology of impulsive behaviour in rats III: the effects of amphetamine, haloperidol, imipramine, chlordiazepoxide and ethanol on a paced fixed consecutive number schedule // Psychopharmacology. (Berl.) 1998. V. 138. No 3-4. P. 295-304.
68. Evenden J. The pharmacology of impulsive behaviour in rats V: the effects of drugs on responding under a dis crimination task using unreliable visual stimuli // Psychopharmacology. (Berl.) 1999. V. 143. No 2. P. 111-122
69. Felton T.M., Kang T.B., Hjorth S., Auerbach S.B. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex // Naunyn-Schmiedeberg's Arch. Pharmacol. 2003. Bd 367. No 3. S. 297-305
70. Ferraro L., Fuxe K., Agnati L., Tanganelli S. et al. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat // Synapse. 2005. V. 55. No 4. P. 230-341.
71. 1 dopamine receptors in mediating the antidepressant effect of imipramine // Pharmacol. Biochem. Behav. 1995. V. 50. No 2. P. 147-151.
72. Getsova V.M., Orlova N.V., Folomkina A.A., Bazyan A.S. The behavioural correlates of dopamine deficit by WAG/Rij rats strain // Eds G. van Luijtelar, G.D. Kuznetsova, A. Coenen, S.A. Chepurnov. The WAG/Rij model of absence epilepsy: The Nijmegan - Russian Federation papers. Netherlands: Nijmegan Institute for Cognition and Information, 2004: P. 293-304.
73. Gerrits M.A.F.M., Pctromilli P., Westenberg H.G.M. et al. Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats // Brain Res. 2002. V. 924. No 1. P. 141-150.
74. Gray T., Wise R.A. Effects of pimozide on lever pressing behavior maintained on an intermittent reinforcement schedule // Pharmacol. Biochem. Behav. 1980 V. 6. P. 931-935.
75. Greengard P., Allen P.D., Nairn A.C. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade // Neuron. 1999. V. 23. No 3. P. 435-447.
76. Gratton A., Wise RA. Drug- and behavior-associated changes in dopamine-related elrctrochemical signals during intravenous cocaine self-administration in rats // J. Neurosci. 1994. V. 14. No 7. P. 4130-4146.
77. Gur E., Lifschytz T., Lerer B., Newman M.E. Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortex // Eur. J. Pharmacol. 2002. V. 457. No 1. P. 37-43.
78. Heffner T.G., Luttinger D., Hartman J.A., Seiden L.S. Regional changes in brain catecholamine turnover in the rat during performance on fixed ratio and variable interval schedules of reinforcement. // Brain Res. 1981. V. 214. No 1. P. 215-218.
79. Hemby S.E., Martin T.J., Co C. et al. The effects of the intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis // J. Pharm. Exp. Ther. 1995. V. 273. No 3. P. 591-598.
80. Hernandez L., Hoebel B.G. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis // Life Sci. 1988. V. 42. No 18. P. 1705-1712.
81. Hull C.L. Principles of behavior. N.Y.: Appleton, 1943.
82. Hurd Y.L., Weiss F., Koob G.F. et al. Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study // Brain Res. 1989. V. 498. No 2. P. 199-203.
83. Ichimaru Y., Egawa T., Sawa A. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice // Jpn. J. Pharmacol. 1995. V. 68. Ma 1. P. 65-70.
84. Iversen L.L. Function and distribution of peptides in the nervous system // Biochem. Soc. Trans. 1985. V. 13. No 1. P. 35-37.
85. Joseph M.H., Datla K., Young A.M. The interpretation of the measurement of nucleus accumbens dopamine by in vivo dialysis: the kick, the craving or the cognition? // Neurosci Biobehav Rev. 2003. V. 27. No 6. P. 527-541.
86. Johnston J.D., Price S.A., Bristow D.R. Flunitrazepam rapidly reduces GABA(A) receptor subunit protein expression via a protein kinase C-dependent mechanism // Br. J. Pharmacol. 1998. V. 124. No 7. P. 1338-1340.
87. Keck M.E., Sartori S.B., Welt T. et al. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment // J. Neurochem. 2005. V. 92. No 5. P. 1170-1179.
88. Kennett G.A., Pittaway K., Blackburn T.P. Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety // Psychopharmacol. Berl. 1994. V. 114. No 1. P. 90-96.
89. Kennett G.A., Bailey F., Piper D.C., Blackburn T.P. Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety // Psychopharmacol. Berl. 1995. V. 118. No 2. P. 178-182.
90. Kiyatkin E.A., Gratton A. Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food // Brain Res. 1994. V. 652. No 2. P. 225-234.
91. Kokaia M., Pratt G. D., Elmer E. et al. Biphasic differential changes of GABAA receptor subunit mRNA levels in dentate gyrus granule cells following recurrent kindling-induced seizures // Mol. Brain Res. 1994. V. 23. No 3. P. 323-332.
92. Koob G.F. The role of the striatopallidal and extended amygdala systems in drug addiction // Ann. N.Y. Acad. Sci. 1999. V. 907. No 10. P. 445-460.
93. Koob G.F. Neurobiology of addiction // Ann. N.Y. Acad. Sci. 2000. V. 909. No 3. P. 170-185.
94. Koob G.F., Le Moal M. Drug addiction, disregulation of reward, and allostasis // Neuropsychopharmacology. 2001. V. 24. P. 97-129.
95. Koskinen T., Sirvio J. Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task. // Brain Res. Bull. 2001. V. 54. No 1. P. 65-75.
96. Krnjevic K. Chemical nature of synaptic transmission in vertebrates // Physiol. Rev. 1974. V. 54. No 5. P. 418-540.
97. Macdonald R.L., Olsen R.W. GABAA receptor channels // Annu. Rev. Neurosci. 1994. V. 17. P. 569-602.
98. Martel P., Fantino M. Influence of the amount of food ingested on mesolimbic dopaminergic system activity: a microdialysis study // Pharmacol. Biochem. Behav. 1996. V. 55. No 2. P. 297-302.
99. Matrisciano F., Storto M., Ngomba R.T. et al. Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus // Neuropharmacology. 2002. V. 42. No 8. P. 1008-1015.
100. Mayford M., Abel T., Kandel E.R. Transgenic approaches to cognition // Cur. Opin. Neurobiol. 1995. V. 5. P. 141-148.
101. McGregor I.S., Atrens D.M., Jackson D.M. Cocaine facilitation of prefrontal cortex self-stimulation: a microstructural and pharmacological analysis // Psychopharmacology Berl. 1992. V. 106. No 2. P. 239-247
102. Mednikova Y.S., Karnup S.V., Loseva E.V. Cholinergic excitation of dendrites in neocortical neurons // Neuroci. 1998. V. 87. No 4. P. 783-796.
103. Mehta A.K., Ticku M.K. An update on GABA(A) receptors // Brain Res. Rev. 1999. V. 29. P. 196-217.
104. Miller N.E. Central stimulation and other new approaches to motivation and reward. // Am. Psychol. 1958. V. 13. P.100-108.
105. Mochizuki D., Hokonohara T., Kawasaki K., Miki N. Repeated administration of milnacipran induces rapid desensitization of somatodendritic 5-HT1A autoreceptors but not postsynaptic 5-HT1A receptors // J. Psychopharmacol. 2002. V. 16. No 3. P. 253-260.
106. Molcwijk H.E., Van Der Poel A.M., Olivier B. The ambivalent behaviour "stretched approach posture" in the rat as a paradigm to characterize anxiolytic drugs // Psychopharmacol. Berl. 1995. V. 121. No 1. P. 81-90.
107. Moran M.H., Smith S.S. Progesterone withdrawal I: proconvulsant effects // Brain Res. 1998. V. 807. No 1-2. P. 84-90.
108. Morgane P.J., Stern W.C. Relationship of sleep to neuroanatomical circuits, biochemistry and behaviour // Ann. N.Y. Acad. Sci. 1972. V. 193. No 2. P. 95-111.
109. Muscat R., Sampson D., Willner P. Dopaminergic mechanism of imipramine action in an animal model of depression // Biol. Psychiatry. 1990. V. 28. P. 223-230.
110. Nicholson G.M., Blanche T., Mansfield K., Tran Y. Differential blockade of neuronal voltage-gated Na(+) and K(+) channels by antidepressant drugs // Eur. J. Pharmacol. 2002. V. 452. No 1. P. 35-48.
111. Nicoll R.A., Malenka R.C., Kauer J.A. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system // Physiol. Rev. 1990. V. 70. No 2. P. 513-565.
112. Niles L.P., Smith L.J., Tenn C.C. Modulation of c-fos expression in the rat striatum by diazepam // Neurosci. Lett. 1997. V. 236. No 1. P. 5-8.
113. Nomura Y., Kitamnra Y., Ohnuki T. et al. Alterations in acetylcholine, NMDA, benzodiazepine receptors and protein kinase C in the brain of the senescence-accelerated mouse: an animal model useful for studies on cognitive enhancers // Behav. Brain Res. 1997. V. 83. No 1-2. P. 51-55.
114. Olds M.E. Dopamine agonists prevent or counteract the suppression of brain stimulation reward by fenfluramine // Pharmacol. Biochem. Behav. 1995. V. 50. No 1. P 41-48
115. Olds J., Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain // J. Comp. Physiol. Psychol. 1954. V. 17. No 6. P. 419-428.
116. Ossowsk G., Nowak G., Klenk-Majewskal B. et al. Effect of imipramine on brain D-1 and 5-HT-2A receptors in a chronic unpredictable stress model in rats // Pol. J. Pharmacol. 2002. V. 54. No 2. P. 89-93.
117. Pettit H.O., Ettenberg A., Bloom F.E., Koob G.F. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats // Psychopharmacology. 1984. V. 84. P. 167-173.
118. Phillips A.G., Pfaus J.G., Blaha C.D. Dopamine and motivated behavioninsights provided in vivo analysis // The mesolimbic dopamine system: from motivation to action / Eds P. Willner, J. Scueel-Kruger. Willey, Chichester, London: UK. 1991. P. 199-224.
119. Phillips A.G., Coury A., Fiorino D. et al. Self-stimulation of the ventral tegmental area enhances dopamine release in the nucleus accumbens: a microdialysis study. // Ann. N.Y. Acad. Sci. 1992. V. 654. P. 199-206.
120. Pratt G. D., Kokaia M., Bengzon J., et al. Differential regulation of N-methyl-D-aspartate receptor subunit messenger RNAs in kindling-induced epileptogenesis // Neurosci. 1993. V. 57. P. 307-318.
121. Quintin P., Thomas P. Efficacy of atypical antipsychotics in depressive syndromes // Encephale. 2004. V. 30. No 6. P. 583-589.
122. Ready D.S., Kulkarni S.K. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice // Methods Find. Exp. Clin. Pharmacol. 1997. V. 19. No 10. P. 665-681.
123. Rickels K., Rynn M. Pharmacotherapy of generalized anxiety disorder // J. Clin. Psychiatry. 2002. V. 63. Suppl. 14. P. 9-16.
124. Robertson M.V., Leslie C.A., Bennett J.P. Aparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment // Brain Res. 1991. V. 538. P. 337-339.
125. Rogoz Z., Skuza G. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors // Pol. J. Pharmacol. 2001. V. 53. No 6. P. 571-576.
126. Rosel P., Arranz B., Urretavizcaya M. et al. Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT(2A) receptors in Brodmann areas and brain hemispheres // Psychiatry Res. 2002. V. 111. No 2-3. P. 105-115
127. Rossetti Z.L., Hmaidan Y., Gessa G.L. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats // Eur. J. Pharmacol. 1992. V. 221. P. 227-234.
128. Roth R.H., Wolf M.E., Deutch A.Y. Neurochemistry of midbrain dopamine systems // Psychopharmacology: The Third Generation of Progress / Eds H.Y. Meltzer., N.Y.: Raven Press, 1987. P. 81-96.
129. Rupprecht R., Holsboer F. Neuroactive steroids: mechanisms of action neuropsychopharmacological perspectives // Trend. Neurosci. 1999. V. 22. No 9. P. 410-416.
130. Salamone J.D. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation // Behav. Brain Res. 1994. V. 61. No 2. P. 117-133.
131. Salamone J.D., Cousins M.S., Snyder B.J. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis // Neurosci. Biobehav. Rev. 1997. V. 21. No 3. P. 341-359.
132. Sanchez C. Stress-induced vocalisation in adult animals. A valid model of anxiety? // Eur. J. Pharmacol. 2003. V. 463. No 1-3. P. 133-143.
133. Schulz C., Lehnert H. Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor, a microdialysis study // Neuroendocrinology. 1996. V. 63. P. 454-458.
134. Shepherd J.K., Grewal S.S., Fletcher A. et al. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. // Psychopharmacol. Berl. 1994. V. 116. No 1. P. 56-64.
135. Skinner B.F. Science and human behavior. New York. MacMillan. 1953.
136. Smialowska M., Szewczyk B., Branski P. et al. Effect of chronic imipramine or electroconvulsive shock on the expression of mGluRla and mGluR5a immunoreactivity in rat brain hippocampus // Neuropharmacology. 2002. V. 42. No 8. P. 1016-1023.
137. Takamori K., Yoshida S., Okuyama S. Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test // Life Sci. 2001. V. 69. No 16. P. 1919-1926.
138. Tips receptor and ion channel nomenclature // Trends Pharmacol. Sci. 1997. V. 18. Suppl. 1.
139. Thorndike E.L. Animal intelligence. N.Y.: MacMillan, 1911.
140. Tottori K., Miwa T., Uwahodo Y., Yamada S. et al. Antidepressant-like responses to the combined sigma and 5-HT1A receptor aconist OPC-14523 // Neuropharmacology. 2001. V. 41. No 8. P. 976-988.
141. Varona A., Gil J., Saracibar G., Maza J.L. et al. Effects of imipramine treatment on delta-opioid receptors of the rat brain cortex and striatum // Arzneimittelforschung. 2003. Bd. 53. No 1. S. 21-25.
142. Weiss F., Ciccocioppo R., Parsons L.H. et al. Compulsive drug-seeking behaviour and relapse. Neuroadaptation, stress, and conditioning factors // Ann. N. Y. Acad. Sci. 2001. V. 937. No 1. P. 1-26
143. Weiss F., Markou A., Lorang M.T., Koob G.F. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration // Brain Res. 1992. V. 593. No 3. P. 314-318.
144. Wilson M.A. GABA physiology: modulation by benzodiazepines and hormones // Crit. Rev. Neurobiol. 1996. V. 10. No 1. P. 1-37.
145. Winstanley C.A., Dalley J.W., Theobald D.E., Robbins T.W. Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats // Psychopharmacology (Berl). 2003. V. 170. No 3. P. 320-331.
146. Winstanley C.A., Theobald D.E., Dalley J.W., Robbins T.W. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders // Neuropsychopharmacology. 2005. V. 30. No 4. P. 669-682.
147. Wise R.A. Catecholamine theories of reward: a critical review // Brain Res. 1978. V. 152. No 2. P. 215-247.
148. Wise R.A. Neuroleptic attenuation of intracranial self-stimulation: reward or performance deficits? // Life Sci. 1978. V. 22. No 7. P. 535-542.
149. Wood M.D., Thomas D.R., Watson J.M. Therapeutic potential of serotonin antagonists in depressive disorders // Expert. Opin. Investig. Drugs. 2002. V. 11. No 4. P. 457-467.